SRPK1 acetylation modulates alternative splicing to regulate cisplatin resistance in breast cancer cells
10.1038/s42003-020-0983-4
Saved in:
Main Authors: | Wang, C., Zhou, Z., Subhramanyam, C.S., Cao, Q., Heng, Z.S.L., Liu, W., Fu, X., Hu, Q. |
---|---|
Other Authors: | PHYSIOLOGY |
Format: | Article |
Published: |
Nature Research
2021
|
Online Access: | https://scholarbank.nus.edu.sg/handle/10635/198726 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | National University of Singapore |
Similar Items
-
ROLE OF SRPK1-MODULATED ALTERNATIVE SPLICING IN CISPLATIN RESISTANCE IN BREAST CANCER CELLS
by: WANG CHENG
Published: (2019) -
Linking aberrant splicing to cardiac aging : unravelling SRPK2
by: Meroshini, M.
Published: (2016) -
CRISPR/Cas9-mediated double knockout of SRPK1 and SRPK2 in a nasopharyngeal carcinoma cell line
by: Pongphol Prattapong, et al.
Published: (2020) -
GLIPR1 modulates the response of cisplatin-resistant human lung cancer cells to cisplatin
by: Gong X., et al.
Published: (2019) -
EP300 and SIRT1/6 co-regulate lapatinib sensitivity via modulating FOXO3-acetylation and activity in breast cancer
by: Zimam Mahmud, et al.
Published: (2020)